Literature DB >> 19289922

A review of primary hyperparathyroidism.

Beverly B Owens1.   

Abstract

Primary hyperparathyroidism is the inappropriate secretion of parathyroid hormone and is the most common cause of hypercalcemia. Most patients with primary hyperparathyroidism are asymptomatic, and the disease is more common in postmenopausal women than in older men. Primary hyperparathyroidism can be treated with medication and long-term monitoring; however, surgical removal of the affected parathyroid gland is the definitive treatment. Rarely occurring, parathyroid crisis must be treated promptly to prevent deleterious effects to the patient. The patient experiencing parathyroid crisis benefits from the infusion nurse's knowledge of drug and fluid therapies and expertise in peripheral access.

Entities:  

Mesh:

Year:  2009        PMID: 19289922     DOI: 10.1097/NAN.0b013e318198d483

Source DB:  PubMed          Journal:  J Infus Nurs        ISSN: 1533-1458


  4 in total

1.  Mandibular brown tumor as the first manifestation of primary hyperparathyroidism: A case report.

Authors:  Muna Alhusban; Zaid H Baqain
Journal:  Saudi Dent J       Date:  2010-11-18

2.  Ultrasound features of malignancy in the preoperative diagnosis of parathyroid cancer: a retrospective analysis of parathyroid tumours larger than 15 mm.

Authors:  Paul S Sidhu; Nadia Talat; Preena Patel; Nicola J Mulholland; Klaus-Martin Schulte
Journal:  Eur Radiol       Date:  2011-05-10       Impact factor: 5.315

3.  Unusual presentation of primary hyperparathyroidism: report of three cases.

Authors:  Ruibin Huang; Ruyao Zhuang; Yuan Liu; Tianti Li; Jiexiong Huang
Journal:  BMC Med Imaging       Date:  2015-07-16       Impact factor: 1.930

Review 4.  [Maxillary brown tumor revealing primary hyperparathyroidism: apropos of a case and review of the literature].

Authors:  Fassih Malika; Loubna Taali; Mohamed Akssim; Abada Reda; Sami Rouadi; Mohamed Mahtar; Mohamed Roubal; Mustapha Essaadi; Mohamed Fatmi El Kadiri
Journal:  Pan Afr Med J       Date:  2013-01-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.